BackGreat Tree Pharmacy , Ltd. Overview

Great Tree Pharmacy , Ltd. Receivables

Track Great Tree Pharmacy , Ltd.'s receivables ($1.2B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.17B
↑ 5.78% YoYΔ $63.92M vs prior year quarter

Peer trimmed avg / median

Loading

Great Tree Pharmacy , Ltd. Receivables History

Loading

Great Tree Pharmacy , Ltd. vs. peers: Receivables Comparison

Loading

Great Tree Pharmacy , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Great Tree Pharmacy , Ltd. (6469.TWO) FAQ

As of the most recent data (June 2026), 6469.TWO shows a receivables of $1.2B. That compares with $1.1B in the prior-year period — up 5.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6469.TWO's receivables is now $1.2B (was $1.1B) — a 5.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Great Tree Pharmacy , Ltd. is outperforming or lagging.

Tracking 6469.TWO's receivables over time shows whether Great Tree Pharmacy , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $1.1B in the prior-year period — up 5.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Great Tree Pharmacy , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.2B) with ownership activity and broader fundamentals.